{"id":533841,"date":"2021-03-12T10:00:01","date_gmt":"2021-03-12T10:00:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=533841"},"modified":"2021-03-12T10:00:01","modified_gmt":"2021-03-12T10:00:01","slug":"national-allergy-and-sinus-group-aspire-allergy-sinus-acquires-albuquerques-breathe-america","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/national-allergy-and-sinus-group-aspire-allergy-sinus-acquires-albuquerques-breathe-america_533841.html","title":{"rendered":"National Allergy and Sinus Group, Aspire Allergy & Sinus, Acquires Albuquerque\u2019s Breathe America"},"content":{"rendered":"
\"National<\/a><\/p>\n
\n
Acquisition of Albuquerque\u2019s Breathe America by Aspire Allergy & Sinus will bring new treatment options to Albuquerque allergy sufferers while keeping the doctors they have come to know and love at Breathe America.<\/div>\n<\/div>\n<\/div>\n

Aspire Allergy & Sinus, an allergy and sinus group that provides nationwide services is announcing the acquisition of Albuquerque-based Breathe America.<\/span> <\/span><\/p>\n

The acquisition will allow Aspire to bring new services to allergy sufferers in Albuquerque just in time for the spring allergy season, including <\/span>allergy drops<\/span><\/span><\/a><\/span>, a treatment that is equally as effective as allergy shots and much more convenient. <\/span><\/span><\/p>\n

Aspire also plans to bring the innovative <\/span><\/span>ExACT Immunoplasty<\/span><\/span><\/a><\/span> to Albuquerque, a treatment that is equivalent to five years of allergy shot therapy and gives allergy relief in just three injections. <\/span><\/span><\/p>\n

Aspire will also offer an in-office CT scanner and a variety of in-office sinus procedures to make it easy for Albuquerque patients to receive the allergy and sinus care they need all under one roof.<\/span><\/span><\/p>\n

Though management is changing, Breathe Amercia’s Dr. Richard Wachs and Dr. Roland Gerencer will continue to be the primary medical providers when Aspire takes over.<\/span><\/span><\/p>\n

This is Aspire’s first entry into New Mexico, and the company has future plans to expand into the Southwest region in the coming years.<\/span><\/p>\n

Aspire Allergy & Sinus<\/span><\/strong><\/span><\/p>\n

Known for making new and innovative allergy therapies available, Aspire made<\/span><\/span> <\/span><\/span>allergy drops<\/span><\/span><\/a> a household name when they launched in 2012 and just recently introduced an exceptionally fast way to treat allergies, the<\/span><\/span> <\/span><\/span>ExACT Immunoplasty procedure<\/span><\/span><\/a>. <\/span><\/span>This procedure treats allergies in just eight weeks, rather than years.<\/span><\/span><\/p>\n

For more information, please visit <\/span><\/span>https:\/\/www.aspireallergy.com<\/span><\/span><\/a><\/span><\/p>\n

Media Contact<\/span>
Company Name:<\/strong> OtterPR<\/a>
Contact Person:<\/strong> Allie McLaughlin
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> 800.648.6854
Country:<\/strong> United States
Website:<\/strong> www.OtterPR.com<\/a><\/p>\n

<\/object>\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

Acquisition of Albuquerque\u2019s Breathe America by Aspire Allergy & Sinus will bring new treatment options to Albuquerque allergy sufferers while keeping the doctors they have come to know and love at Breathe America. Aspire Allergy & Sinus, an allergy and … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,424,405,437,452],"tags":[],"class_list":["post-533841","post","type-post","status-publish","format-standard","hentry","category-Business","category-Family-Parenting","category-Health-Medicine","category-Lifestyle","category-Living"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/533841","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=533841"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/533841\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=533841"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=533841"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=533841"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}